TKNO
Alpha Teknova, Inc.
Price Chart
Latest Quote
$5.21
+0.26 (+5.25%)
Current Price
| Previous Close | $4.95 |
| Open | $5.12 |
| Day High | $5.39 |
| Day Low | $4.87 |
| Volume | 140,137 |
Stock Information
| Shares Outstanding | 53.61M |
| Total Debt | $27.83M |
| Cash Equivalents | $17.78M |
| Revenue | $41.80M |
| Net Income | $-17.17M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $279.33M |
| EPS (TTM) | $-0.31 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $257.20M |
| Sales | $41.80M |
| Income | $-17.17M |
| Book/sh | $1.28 |
| Cash/sh | $0.33 |
| Employees | 158 |
Financial Ratios
| Quick Ratio | 3.40 |
| Current Ratio | 4.59 |
| Debt/Eq | 42.86 |
Returns & Margins
| ROA | -9.29% |
| ROE | -23.92% |
| Gross Margin | 34.01% |
| Operating Margin | -38.80% |
| Profit Margin | -41.07% |
Ownership
| Insider Ownership | 9.32% |
| Institutional Ownership | 84.72% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -21.27 |
| P/S | 6.68 |
| P/B | 4.06 |
Analyst Data
| Recommendation | none |
| Target Price | $9.00 |
Technical Indicators
| SMA20 | $4.63 |
| SMA50 | $3.87 |
| SMA200 | $3.94 |
| RSI | 46.98 |
| ATR | 0.4904 |
| Shares Float | 10.88M |
| Short Float | 10.17% |
| Short Ratio | 8.88 |
| Volatility | 0.63 |
| Rel Volume | 0.68 |
Performance History
| Week | +18.41% |
| Month | +40.05% |
| Quarter | +82.81% |
| 6 Months | +12.28% |
| YTD | +33.59% |
| Year | -3.34% |
| 3 Years | +33.25% |
| 10 Years | -79.16% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $5.21 | 140,137 |
| 2026-06-17 | $4.95 | 389,700 |
| 2026-06-16 | $4.61 | 439,500 |
| 2026-06-15 | $4.13 | 153,300 |
| 2026-06-12 | $4.20 | 148,700 |
| 2026-06-11 | $4.40 | 116,600 |
| 2026-06-10 | $4.47 | 96,300 |
| 2026-06-09 | $4.46 | 151,600 |
| 2026-06-08 | $4.65 | 120,600 |
| 2026-06-05 | $4.56 | 205,600 |
| 2026-06-04 | $5.43 | 232,300 |
| 2026-06-03 | $5.13 | 220,900 |
| 2026-06-02 | $5.18 | 149,700 |
| 2026-06-01 | $5.37 | 421,400 |
| 2026-05-29 | $5.40 | 203,800 |
| 2026-05-28 | $4.66 | 237,600 |
| 2026-05-27 | $4.00 | 193,800 |
| 2026-05-26 | $3.99 | 177,700 |
| 2026-05-22 | $3.89 | 134,000 |
| 2026-05-21 | $3.87 | 169,600 |
| 2026-05-20 | $3.70 | 93,000 |
| 2026-05-19 | $3.72 | 96,900 |
| 2026-05-18 | $3.62 | 153,900 |
About Alpha Teknova, Inc.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
đ° Latest News
May 2026's Promising Penny Stocks To Watch
Simply Wall St. âĸ 2026-05-28T18:05:05Z
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Simply Wall St. âĸ 2026-05-09T14:23:31Z
Alpha Teknova Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T07:24:26Z
Alpha Teknova, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T00:37:56Z
Alpha Teknova (TKNO) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T23:07:40Z
Top Penny Stocks To Watch In April 2026
Simply Wall St. âĸ 2026-04-23T12:05:21Z
Favourable Signals For Alpha Teknova: Numerous Insiders Acquired Stock
Simply Wall St. âĸ 2026-03-30T10:22:18Z
Alpha Teknova Conference: TKNO Targets EBITDA Profit by 2027 as Clinical Solutions Gains Traction
MarketBeat âĸ 2026-03-22T15:02:29Z
Alpha Teknova Q4 Earnings Call Highlights
MarketBeat âĸ 2026-02-27T13:46:00Z
Alpha Teknova, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-27T13:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $21,885,000 | $25,084,000 | $21,876,000 | $21,927,000 |
| Cost Of Revenue | $27,079,000 | $30,514,000 | $26,388,000 | $23,944,000 |
| Total Revenue | $40,520,000 | $37,745,000 | $36,684,000 | $41,420,000 |
| Operating Revenue | $38,694,000 | $35,980,000 | $36,684,000 | $41,420,000 |
| Expenses | ||||
| Interest Expense | $710,000 | $687,000 | $833,000 | - |
| Total Expenses | $57,496,000 | $63,891,000 | $67,883,000 | $70,278,000 |
| Other Income Expense | $485,000 | - | $-5,046,000 | $-20,746,000 |
| Net Non Operating Interest Income Expense | $-710,000 | $-687,000 | $-833,000 | $213,000 |
| Interest Expense Non Operating | $710,000 | $687,000 | $833,000 | - |
| Operating Expense | $30,417,000 | $33,377,000 | $41,495,000 | $46,334,000 |
| Selling And Marketing Expense | $6,754,000 | $6,320,000 | $9,330,000 | $9,151,000 |
| General And Administrative Expense | $20,318,000 | $23,150,000 | $25,450,000 | $28,298,000 |
| Other Non Operating Income Expenses | - | - | $142,000 | $55,000 |
| Total Other Finance Cost | - | - | $833,000 | $-213,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Net Interest Income | $-710,000 | $-687,000 | $-833,000 | $213,000 |
| Normalized Income | $-17,642,150 | $-26,745,000 | $-31,633,504 | $-27,478,239 |
| Net Income From Continuing And Discontinued Operation | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Total Operating Income As Reported | $-16,976,000 | $-26,146,000 | $-35,563,000 | $-49,659,000 |
| Net Income Common Stockholders | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Net Income | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Net Income Including Noncontrolling Interests | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Net Income Continuous Operations | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Pretax Income | $-17,201,000 | $-26,833,000 | $-37,078,000 | $-49,391,000 |
| Special Income Charges | $485,000 | $0 | $-5,188,000 | $-20,801,000 |
| Operating Income | $-16,976,000 | $-26,146,000 | $-31,199,000 | $-28,858,000 |
| Depreciation Amortization Depletion Income Statement | $1,148,000 | $1,148,000 | $1,148,000 | $1,148,000 |
| Depreciation And Amortization In Income Statement | $1,148,000 | $1,148,000 | $1,148,000 | $1,148,000 |
| Amortization Of Intangibles Income Statement | $1,148,000 | $1,148,000 | $1,148,000 | $1,148,000 |
| Gross Profit | $13,441,000 | $7,231,000 | $10,296,000 | $17,476,000 |
| Per Share | ||||
| Diluted EPS | $-0.32 | $-0.57 | $-1.16 | $-1.69 |
| Basic EPS | $-0.32 | $-0.57 | $-1.16 | $-1.69 |
| Other | ||||
| Tax Effect Of Unusual Items | $101,850 | $0 | $-41,504 | $-811,239 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,634,000 | $-19,568,000 | $-25,397,000 | $-4,892,000 |
| Total Unusual Items | $485,000 | $0 | $-5,188,000 | $-20,801,000 |
| Total Unusual Items Excluding Goodwill | $485,000 | $0 | $-5,188,000 | $-20,801,000 |
| Reconciled Depreciation | $6,342,000 | $6,578,000 | $5,660,000 | $3,165,000 |
| EBITDA (Bullshit earnings) | $-10,149,000 | $-19,568,000 | $-30,585,000 | $-25,693,000 |
| EBIT | $-16,491,000 | $-26,146,000 | $-36,245,000 | $-28,858,000 |
| Diluted Average Shares | $53,483,075 | $46,745,905 | $31,819,776 | $28,083,563 |
| Basic Average Shares | $53,483,075 | $46,745,905 | $31,819,776 | $28,083,563 |
| Diluted NI Availto Com Stockholders | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Tax Provision | $58,000 | $-88,000 | $-298,000 | $-1,923,000 |
| Other Special Charges | $-485,000 | - | $824,000 | - |
| Amortization | $1,148,000 | $1,148,000 | $1,148,000 | $1,148,000 |
| Research And Development | $2,197,000 | $2,759,000 | $5,567,000 | $7,737,000 |
| Selling General And Administration | $27,072,000 | $29,470,000 | $34,780,000 | $37,449,000 |
| Other Gand A | $20,318,000 | $23,150,000 | $25,450,000 | $28,298,000 |
| Impairment Of Capital Assets | - | $0 | $4,364,000 | $20,801,000 |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $56,832,000 | $69,303,000 | $75,797,000 | $82,329,000 |
| Total Assets | $103,584,000 | $118,769,000 | $128,587,000 | $152,261,000 |
| Total Non Current Assets | $69,073,000 | $75,993,000 | $82,927,000 | $91,121,000 |
| Other Non Current Assets | $1,285,000 | $1,382,000 | $1,852,000 | $2,252,000 |
| Goodwill And Other Intangible Assets | $11,943,000 | $13,091,000 | $14,239,000 | $17,556,000 |
| Other Intangible Assets | $11,943,000 | $13,091,000 | $14,239,000 | $17,556,000 |
| Current Assets | $34,511,000 | $42,776,000 | $45,660,000 | $61,140,000 |
| Other Current Assets | $1,501,000 | $1,267,000 | $1,634,000 | $2,374,000 |
| Inventory | $7,054,000 | $6,801,000 | $11,594,000 | $12,247,000 |
| Receivables | $4,618,000 | $4,312,000 | $3,948,000 | $4,283,000 |
| Accounts Receivable | $4,618,000 | $4,312,000 | $3,948,000 | $4,261,000 |
| Allowance For Doubtful Accounts Receivable | $-23,000 | $-83,000 | $-20,000 | $-22,000 |
| Gross Accounts Receivable | $4,641,000 | $4,395,000 | $3,968,000 | $4,283,000 |
| Cash Cash Equivalents And Short Term Investments | $21,338,000 | $30,396,000 | $28,484,000 | $42,236,000 |
| Cash And Cash Equivalents | $5,912,000 | $3,708,000 | $28,484,000 | $42,236,000 |
| Taxes Receivable | - | - | $0 | $22,000 |
| Prepaid Assets | - | - | - | $2,374,000 |
| Debt | ||||
| Net Debt | $7,211,000 | $9,780,000 | - | - |
| Total Debt | $28,269,000 | $30,172,000 | $30,458,000 | $42,310,000 |
| Long Term Debt And Capital Lease Obligation | $26,393,000 | $24,327,000 | $28,655,000 | $40,087,000 |
| Long Term Debt | $13,123,000 | $9,443,000 | $13,251,000 | $21,976,000 |
| Current Debt And Capital Lease Obligation | $1,876,000 | $5,845,000 | $1,803,000 | $2,223,000 |
| Current Debt | - | $4,045,000 | - | - |
| Other Current Borrowings | - | $4,045,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $34,809,000 | $36,375,000 | $38,551,000 | $52,376,000 |
| Total Non Current Liabilities Net Minority Interest | $27,272,000 | $25,164,000 | $29,676,000 | $41,501,000 |
| Non Current Deferred Liabilities | $879,000 | $827,000 | $919,000 | $1,223,000 |
| Non Current Deferred Taxes Liabilities | $879,000 | $827,000 | $919,000 | $1,223,000 |
| Current Liabilities | $7,537,000 | $11,211,000 | $8,875,000 | $10,875,000 |
| Current Deferred Liabilities | $6,000 | $30,000 | $16,000 | $198,000 |
| Payables And Accrued Expenses | $5,655,000 | $5,336,000 | $7,056,000 | $8,454,000 |
| Interest Payable | $97,000 | $56,000 | $409,000 | $0 |
| Payables | $1,378,000 | $825,000 | $1,493,000 | $2,449,000 |
| Accounts Payable | $1,378,000 | $825,000 | $1,493,000 | $2,449,000 |
| Equity | ||||
| Common Stock Equity | $68,775,000 | $82,394,000 | $90,036,000 | $99,885,000 |
| Total Equity Gross Minority Interest | $68,775,000 | $82,394,000 | $90,036,000 | $99,885,000 |
| Stockholders Equity | $68,775,000 | $82,394,000 | $90,036,000 | $99,885,000 |
| Retained Earnings | $-135,790,000 | $-118,531,000 | $-91,786,000 | $-55,006,000 |
| Gains Losses Not Affecting Retained Earnings | - | - | - | - |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $53,562,154 | $53,409,727 | $40,793,848 | $28,179,423 |
| Share Issued | $53,562,154 | $53,409,727 | $40,793,848 | $28,179,423 |
| Tangible Book Value | $56,832,000 | $69,303,000 | $75,797,000 | $82,329,000 |
| Invested Capital | $81,898,000 | $95,882,000 | $103,287,000 | $121,861,000 |
| Working Capital | $26,974,000 | $31,565,000 | $36,785,000 | $50,265,000 |
| Capital Lease Obligations | $15,146,000 | $16,684,000 | $17,207,000 | $20,334,000 |
| Total Capitalization | $81,898,000 | $91,837,000 | $103,287,000 | $121,861,000 |
| Additional Paid In Capital | $204,564,000 | $200,924,000 | $181,822,000 | $154,891,000 |
| Capital Stock | $1,000 | $1,000 | $0 | $0 |
| Common Stock | $1,000 | $1,000 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Accrued Expenses | $0 | $10,000 | $102,000 | $191,000 |
| Long Term Capital Lease Obligation | $13,270,000 | $14,884,000 | $15,404,000 | $18,111,000 |
| Current Deferred Revenue | $6,000 | $30,000 | $16,000 | $198,000 |
| Current Capital Lease Obligation | $1,876,000 | $1,800,000 | $1,803,000 | $2,223,000 |
| Current Accrued Expenses | $4,277,000 | $4,511,000 | $5,563,000 | $6,005,000 |
| Net PPE | $55,845,000 | $61,520,000 | $66,836,000 | $71,313,000 |
| Accumulated Depreciation | $-17,372,000 | $-12,244,000 | $-7,528,000 | $-4,520,000 |
| Gross PPE | $73,217,000 | $73,764,000 | $74,364,000 | $75,833,000 |
| Leases | $24,868,000 | $24,346,000 | $24,673,000 | $12,093,000 |
| Construction In Progress | $2,917,000 | $2,624,000 | $2,004,000 | $23,714,000 |
| Other Properties | $14,112,000 | $15,767,000 | $16,472,000 | $19,736,000 |
| Machinery Furniture Equipment | $31,320,000 | $31,027,000 | $31,215,000 | $20,290,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $4,117,000 | $4,672,000 | $8,573,000 | $8,368,000 |
| Work In Process | $101,000 | $24,000 | $47,000 | $186,000 |
| Raw Materials | $2,836,000 | $2,105,000 | $2,974,000 | $3,693,000 |
| Other Short Term Investments | $15,426,000 | $26,688,000 | $0 | - |
| Goodwill | - | - | - | $0 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,794,000 | $-13,516,000 | $-26,748,000 | $-55,549,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-8,646,000 | $-12,391,000 | $-18,814,000 | $-27,400,000 |
| Cash Flow From Continuing Operating Activities | $-8,646,000 | $-12,391,000 | $-18,814,000 | $-27,400,000 |
| Operating Gains Losses | $19,000 | $233,000 | $881,000 | $326,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,148,000 | $-1,125,000 | $-7,934,000 | $-28,149,000 |
| Investing Cash Flow | $10,699,000 | $-27,275,000 | $-7,737,000 | $-28,149,000 |
| Cash Flow From Continuing Investing Activities | $10,699,000 | $-27,275,000 | $-7,737,000 | $-28,149,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $15,104,000 | $22,503,000 | $0 |
| Financing Cash Flow | $151,000 | $14,890,000 | $12,799,000 | $10,267,000 |
| Cash Flow From Continuing Financing Activities | $151,000 | $14,890,000 | $12,799,000 | $10,267,000 |
| Net Other Financing Charges | $-1,170,000 | $-378,000 | $-32,000 | $-307,000 |
| Net Common Stock Issuance | $0 | $15,104,000 | $22,503,000 | $0 |
| Common Stock Issuance | $0 | $15,104,000 | $22,503,000 | $0 |
| Other | ||||
| Issuance Of Debt | $1,110,000 | $0 | $0 | $10,135,000 |
| Interest Paid Supplemental Data | $1,460,000 | $1,552,000 | $1,749,000 | $101,000 |
| Income Tax Paid Supplemental Data | $2,000 | $39,000 | $0 | $0 |
| End Cash Position | $5,912,000 | $3,708,000 | $28,484,000 | $42,236,000 |
| Beginning Cash Position | $3,708,000 | $28,484,000 | $42,236,000 | $87,518,000 |
| Changes In Cash | $2,204,000 | $-24,776,000 | $-13,752,000 | $-45,282,000 |
| Proceeds From Stock Option Exercised | $211,000 | $164,000 | $328,000 | $439,000 |
| Net Issuance Payments Of Debt | $1,110,000 | $0 | $-10,000,000 | $10,135,000 |
| Net Long Term Debt Issuance | $1,110,000 | $0 | $-10,000,000 | $10,135,000 |
| Long Term Debt Issuance | $1,110,000 | $0 | $0 | $10,135,000 |
| Net Investment Purchase And Sale | $11,847,000 | $-26,275,000 | $0 | $0 |
| Sale Of Investment | $29,000,000 | $4,000,000 | $0 | $0 |
| Purchase Of Investment | $-17,153,000 | $-30,275,000 | $0 | - |
| Net PPE Purchase And Sale | $-1,148,000 | $-1,000,000 | $-7,737,000 | $-28,149,000 |
| Sale Of PPE | $0 | $125,000 | $197,000 | $0 |
| Purchase Of PPE | $-1,148,000 | $-1,125,000 | $-7,934,000 | $-28,149,000 |
| Change In Working Capital | $-2,679,000 | $-873,000 | $2,249,000 | $-7,334,000 |
| Change In Other Working Capital | $-10,000 | $-92,000 | $-89,000 | $-82,000 |
| Change In Other Current Assets | $97,000 | $470,000 | $400,000 | $-2,072,000 |
| Change In Payables And Accrued Expense | $543,000 | $-983,000 | $1,163,000 | $760,000 |
| Change In Accrued Expense | $73,000 | $-389,000 | $1,936,000 | $188,000 |
| Change In Payable | $470,000 | $-594,000 | $-773,000 | $572,000 |
| Change In Account Payable | $470,000 | $-594,000 | $-773,000 | $572,000 |
| Change In Prepaid Assets | $-567,000 | $-18,000 | $131,000 | $64,000 |
| Change In Inventory | $-2,368,000 | $244,000 | $330,000 | $-7,550,000 |
| Change In Receivables | $-374,000 | $-494,000 | $314,000 | $1,546,000 |
| Changes In Account Receivables | $-374,000 | $-494,000 | $292,000 | $380,000 |
| Other Non Cash Items | $-119,000 | $507,000 | $635,000 | $607,000 |
| Stock Based Compensation | $3,429,000 | $3,666,000 | $4,137,000 | $3,711,000 |
| Provisionand Write Offof Assets | $2,115,000 | $4,549,000 | $323,000 | $697,000 |
| Asset Impairment Charge | $68,000 | $130,000 | $4,385,000 | $20,826,000 |
| Amortization Of Securities | $-614,000 | $-344,000 | $0 | - |
| Deferred Tax | $52,000 | $-92,000 | $-304,000 | $-1,930,000 |
| Deferred Income Tax | $52,000 | $-92,000 | $-304,000 | $-1,930,000 |
| Depreciation Amortization Depletion | $6,342,000 | $6,578,000 | $5,660,000 | $3,165,000 |
| Depreciation And Amortization | $6,342,000 | $6,578,000 | $5,660,000 | $3,165,000 |
| Gain Loss On Sale Of PPE | $19,000 | $233,000 | $57,000 | $326,000 |
| Net Income From Continuing Operations | $-17,259,000 | $-26,745,000 | $-36,780,000 | $-47,468,000 |
| Repayment Of Debt | - | $0 | $-10,000,000 | $0 |
| Long Term Debt Payments | - | $0 | $-10,000,000 | $0 |
| Amortization Cash Flow | - | $1,100,000 | $1,100,000 | $1,100,000 |
| Amortization Of Intangibles | - | $1,100,000 | $1,100,000 | $1,100,000 |
| Depreciation | - | $5,400,000 | $4,500,000 | $2,000,000 |
Fetched: 2026-06-18